TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.07-0.05-0.380.35
Low estimate-0.07-0.05-0.380.35
High estimate-0.07-0.05-0.380.35
Year ago EPS12.39-3.1311.96-0.38
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate500k500k2M9M
Low estimate500k500k2M9M
High estimate500k500k2M9M
Year ago sales28.56M20.92M69.96M2M
Sales growth (year/est)-98.20%-97.60%-97.10%350.00%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-3.04-0.57-1.110.06
Actual EPS12.39-3.138.23-0.37
Difference15.43-2.569.34-0.43
Surprise %507.60%-449.10%841.40%-716.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.07-0.05-0.380.35
7 days ago-0.07-0.05-0.380.35
30 days ago0.060.030.190.13
60 days ago-1.12-0.69-0.79-0.81
90 days ago-1.12-0.69-0.79-0.81
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTXMDIndustrySector(s)S&P 500
Current qtr.-100.60%N/AN/AN/A
Next qtr.98.40%N/AN/AN/A
Current year-103.20%N/AN/AN/A
Next year192.10%N/AN/AN/A
Next 5 years (per annum)17.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A